#027: April 13th, 2021 - Longevity Marketcap Telemetry

1. Announcements

2. Capital Raise Radar

3. Last Week in Longevity

4. Longevity Futures

5. Longevity Jobs

6. New Companies on Longevity List 

7. Measuring Progress

8. My Links

*Disclaimer: None of this should be taken as financial advice. It is for educational purposes only.

Mission: To grow a wave of passionate people building, funding, and championing technologies that extend healthy human lifespan. 

If you believe in this mission please consider supporting through Patreon or Longevity List Merch.

📢 Announcements 

• Every Friday @ 12PM - 5PM EDT. Longevity Virtual Coworking. If you are working on longevity or thinking about getting into the longevity industry, please join me for an experimental virtual longevity coworking space using the Pluto.Video web app. (Sign in with Google account. No sign-up required.) 

  • Bring something to work on.

  • Feel free to ask questions. 

  • Help out. Connect.

  • I plan on holding this weekly. It’s free. (Room Link)  

• The 1% Bet for Longevity-- a website initiative.29 people have now signed up for the 1% Bet for Longevity Pledge. My goal is to get to 50,000 people and at least 100 companies to pledge 1% of their resources towards funding longevity companies and research by end of the year. 

📡 Capital Raise Radar

I do not endorse or have affiliations with any of the companies listed below. This is not an offer to buy or sell securities. This is for informational purposes only. If you have intel on any other longevity companies currently raising please email me. It’s free.

• Oncolife Therapeutics // Raising $2M - $3M // Slide deck

  • Developing drugs that modulate stem cell activity to treat cancer and aging

  • Team: Guy Barry (QIMR Berghofer Medical Research Institute, Brisbane, Australia), Paul Baldock (The Garvan Institute of Medical Research, Sydney, Australia)

• Gerostate Alpha // Raising $? // WeFunder page

  • High-throughput phenotypic screen platform to discover anti-aging drugs.

  • A spinout from the Buck Institute for Aging. Y Combinator-backed startup.

  • Team includes academics from the Buck Institute: Simon Melov, Mark Lucanic, Gordon Lithgow. 

  • Crowdfunding on WeFunder. Open to all investors, even retail.

  • Already raised $2.1M on a $15M valuation.

• Oisin Biotechnologies // Raising $5M // Slide Deck

  • Senolytic gene therapy using a lipid-protein nanoparticle delivery vehicle. Kills cells that express the p16 gene -- a marker of senescent cells. Inducible apoptosis gene with a p16 promoter triggered by a chemical dimerizer.

  • Team: Matthew Scholz (Immusoft), Gary Hudson.

  • Seed